ExecPay

Nancy E. Denyes

Overview20232022202120202019

Overview

Nancy E. Denyes received an average of $695K in total compensation, including $368K in salary, at aTYR PHARMA from 2019 to 2023.

Source: SEC filings on April 5, 2024, March 22, 2022, March 23, 2021, and April 2, 2020.
Denyes' 2023 pay

Related executives

We found nine more executives who work or worked at aTYR PHARMA.

Sanjay Shukla

aTYR PHARMA

Chief Executive Officer

8

Jill Broadfoot

aTYR PHARMA

Chief Financial Officer

6

Ashraf Amanullah

aTYR PHARMA

Former Senior Vice President, Biologics, Development and Manufacturing

1

David King

aTYR PHARMA

Chief Scientific Officer

2

John Mendlein

aTYR PHARMA

Chief Executive Officer

4

Sanuj Ravindran

aTYR PHARMA

Former Chief Business Officer

2

Kelly Blackburn

aTYR PHARMA

Vice President, Clinical Affairs

1

David Weiner

aTYR PHARMA

Chief Medical Officer

2

News

You may also like

aTYR PHARMA